[1] 张召才.心肌纤维化的研究进展[J].临床心血管病杂志,2004, 20(1):58
[2] Morin D P, Bernard M L, Madias C A, et al. The state of the art: atrial fibrillation epidemiology, prevention, and treatment[J]. Mayo Clinic Proceedings, 2016,91(12):1778
[3] 王增夏,王贺,邱承杰,等.心房颤动发病机制的研究进展[J].中国医药导报,2018, 15(15): 26
[4] 王学文.依那普利,厄贝沙坦和血管紧张素-(1-7)对快速心房起搏犬心房肌钠通道电流及其通道基因表达的影响[D].天津:天津医科大学,2010
[5] 赵珺.血管紧张素-(1-7)对快速心房起搏犬心房重构的影响及其作用机制[D].天津:天津医科大学,2014
[6] Zarubin T, Han J. Activation and signaling of the p38 MAP kinase pathway[J].Cell Res, 2005,15(1):11
[7] 赵金红.p38MAPK信号通路与心脏重构关系的研究进展[J].医学综述,2013, 19(13): 2312
[8] 彭晓波,梁贵友.p38MAPK与心肌缺血/再灌注损伤的研究进展[J]. 医学综述, 2017, 23(18): 3537
[9] Lu Y Y, Chen Y C, Kao Y H, et al. Extracellular matrix of collagen modulates arrhythmogenic activity of pulmonary veins through p38 MAPK activation[J]. J Mol Cell Cardiol, 2013, 59(2013): 159
[10] Zhang D L, Liu X, Chen X Q, et al. Role of the MAPKs/TGF-beta 1/TRAF6 Signaling Pathway in Atrial Fibrosis of Patients with Chronic Atrial Fibrillation and Rheumatic Mitral Valve Disease[J].Cardiol, 2014,129(4):216
[11] Cheng W, Zhu Y, Wang H D. The MAPK pathway is involved in the regulation of rapid pacing-induced Ionic Channel remodeling in rat atrial myocytes[J]. Mol Med Rep, 2016, 13(3): 2677
[12] Sheng L, Shen Q L, Huang K, et al. Upregulation of beta 3-adrenergic receptors contributes to atrial structural remodeling in rapid pacing induced atrial fibrillation canines[J]. Cell Physiol Biochemi, 2012, 30(2): 372
[13] Mehta P K, Griendling K K. Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system[J]. Am J Physiol Cell Physiol, 2007,292(1): C82
[14] Grobe J L, Mecca A P, Lingis M, et al. Prevention of angiotensin II-induced cardiac remodeling by angiotensin-(1-7)[J]. Am J Physiol Heart Circ Physiol, 2007,292(2): H736
[15] Sim?觛es E A, Silveira K D, Ferreira A J, et al. ACE2,angiotensin-(1-7)and Mas receptor axis in inflammation and fibrosis[J]. Br J Pharmacol, 2013,169(3): 477
[16] 杨胜荣. 依那普利,依贝沙坦及血管紧张素-(1-7)对慢性房颤犬模型心房重构的影响[D].天津:天津医科大学,2008
[17] 李杨,王学文,李健,等.依那普利、厄贝沙坦及血管紧张素-(1-7)对快速心房起搏犬血管紧张素转换酶的影响[J].中国心脏起搏与心电生理杂志,2011,25(1): 65
[18] Liang B, Wang X, Zhang N, et al. Angiotensin-(1-7)attenuates angiotensin II-induced ICAM-1,VCAM-1,and MCP-1 expression via the MAS receptor through suppression of P38 and NF-κB Pathways in HUVECs[J]. Cell Physiol Biochem, 2015, 35(6): 2472
[1]王爱芬,崔利军,马向红.非瓣膜性心房颤动左心房/左心耳血栓形成的相关因素分析[J].天津医科大学学报,2015,21(02):130.
WANG Ai-fen,CUI Li-jun,MA Xiang-hong.Related factors of left atrial or left atrial appendage thrombus formation in patients with non-valvular atrial fibrillation[J].Journal of Tianjin Medical University,2015,21(05):130.
[2]陈延勋,李广平. 非瓣膜性心房颤动患者尿酸与CHADS2、CHA2DS2-VASc评分的关系[J].天津医科大学学报,2015,21(03):185.
CHEN Yan-xun,LI Guang-ping. Relationship between uric acid and CHADS2/CHA2DS2-VASc Score in patients with nonvalvular atrial fibrillation[J].Journal of Tianjin Medical University,2015,21(05):185.
[3]崔占前,徐延敏.脂蛋白相关性磷脂酶A2及高敏C反应蛋白与左心房内径的关系[J].天津医科大学学报,2015,21(03):196.
CUI Zhan-qian,XU Yan-min.Relationship between plasma lipoprotein-associated phospholipase A2, high sensitivity C reactive protein and left atrial diameter[J].Journal of Tianjin Medical University,2015,21(05):196.
[4]付伟伟,李国东,王 喆.HDL-C与非瓣膜性心房颤动左心房/左心耳血栓形成的关系[J].天津医科大学学报,2015,21(06):498.
FU Wei-wei,LI Guo-dong,WANG Zhe.Relationship between high-density lipoprotein cholesterol and left atrial / left atrial appendage thrombus in non-valvular atrial fibrillation patients[J].Journal of Tianjin Medical University,2015,21(05):498.
[5]张彦月,林文华.vWF及血浆D-二聚体水平对非瓣膜性心房颤动患者血栓形成的诊断及临床预后价值[J].天津医科大学学报,2016,22(02):101.
ZHANG Yan-yue,LIN Wen-hua.Value of vWF and?D-dimer for thrombosis and prognosis in patients with non-valvular atrial fibrillation[J].Journal of Tianjin Medical University,2016,22(05):101.
[6]刘运龄,赵艳淑,刘恩照,等.不同类型心房颤动患者心脏结构及B型钠尿肽水平的变化[J].天津医科大学学报,2016,22(06):522.
LIU Yun-ling,ZHAO Yan-shu,LIU En-zhao,et al.Relationship between plasma leves B-type natriuretic peptide and cardiac structure in patients with different types of atrial fibrillation[J].Journal of Tianjin Medical University,2016,22(05):522.
[7]张邦滢 综述,李广平 审校.新型抗心律失常药物在心房颤动中的应用[J].天津医科大学学报,2017,23(01):90.
[8]杜春蕾,郭 牧,张云强,等.尼非卡兰和胺碘酮治疗急性心肌梗死新发房颤有效性和安全性对比研究[J].天津医科大学学报,2019,25(05):471.
DU Chun-lei,GUO Mu,ZHANG Yun-qiang,et al.Comparison of nifekalant and amiodarone in the treatment of new-onset atrial fibrillation in acute myocardial infarction patients[J].Journal of Tianjin Medical University,2019,25(05):471.
[9]张茂芃,陈炳伟,卢成志,等.脉冲场消融治疗心房颤动的短期及长期安全性临床研究[J].天津医科大学学报,2023,29(06):636.
ZHANG Mao-peng,CHEN Bing-wei,LU Cheng-zhi,et al.The short-term and long-term safety clinical trial of pulse field ablation to treat atrial fibrillation[J].Journal of Tianjin Medical University,2023,29(05):636.